HTR3A and Cognitive impairment: Among 5-HT3A antagonists, those that can cross the BBB are suitable for treating neurological diseases such as memory and cognitive impairment, through their interaction mechanism in the CNS, while agents that cannot pass BBB are suitable for treating IBS, nausea, and vomiting [23].